Deepa Rungta

726 total citations
17 papers, 392 citations indexed

About

Deepa Rungta is a scholar working on Molecular Biology, Genetics and Immunology. According to data from OpenAlex, Deepa Rungta has authored 17 papers receiving a total of 392 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 9 papers in Genetics and 3 papers in Immunology. Recurrent topics in Deepa Rungta's work include Retinoids in leukemia and cellular processes (9 papers), Estrogen and related hormone effects (8 papers) and Peroxisome Proliferator-Activated Receptors (4 papers). Deepa Rungta is often cited by papers focused on Retinoids in leukemia and cellular processes (9 papers), Estrogen and related hormone effects (8 papers) and Peroxisome Proliferator-Activated Receptors (4 papers). Deepa Rungta collaborates with scholars based in United States. Deepa Rungta's co-authors include Rosemary M. Cesario, Diane L. Crombie, Richard A. Heyman, Deepak S. Lala, Kay Klausing, Mark D. Leibowitz, Timothy A. Grese, Nathalie Picard, Pierre‐Yves Michellys and Xianping Lu and has published in prestigious journals such as Journal of Biological Chemistry, Nature Medicine and Blood.

In The Last Decade

Deepa Rungta

16 papers receiving 373 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Deepa Rungta United States 11 265 134 65 63 35 17 392
Pierre Antony France 14 225 0.8× 133 1.0× 69 1.1× 31 0.5× 33 0.9× 20 537
Bonnie F. Tate United States 11 248 0.9× 108 0.8× 52 0.8× 44 0.7× 36 1.0× 14 367
Stacie S. Canan Koch United States 7 271 1.0× 122 0.9× 148 2.3× 70 1.1× 45 1.3× 10 401
Hiroki Umemiya Japan 10 272 1.0× 100 0.7× 146 2.2× 58 0.9× 35 1.0× 15 432
Michael McClurg United States 6 503 1.9× 257 1.9× 41 0.6× 141 2.2× 85 2.4× 9 597
Sabrina Kammerer France 6 350 1.3× 219 1.6× 39 0.6× 84 1.3× 75 2.1× 7 411
Sandra Timm Pearce United States 7 253 1.0× 296 2.2× 29 0.4× 23 0.4× 15 0.4× 7 518
Carole Peluso‐Iltis France 12 454 1.7× 301 2.2× 69 1.1× 57 0.9× 172 4.9× 26 691
Debra K. Breuer United States 5 213 0.8× 78 0.6× 29 0.4× 22 0.3× 26 0.7× 5 394
Qiao Liao China 7 331 1.2× 51 0.4× 57 0.9× 111 1.8× 11 0.3× 9 490

Countries citing papers authored by Deepa Rungta

Since Specialization
Citations

This map shows the geographic impact of Deepa Rungta's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Deepa Rungta with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Deepa Rungta more than expected).

Fields of papers citing papers by Deepa Rungta

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Deepa Rungta. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Deepa Rungta. The network helps show where Deepa Rungta may publish in the future.

Co-authorship network of co-authors of Deepa Rungta

This figure shows the co-authorship network connecting the top 25 collaborators of Deepa Rungta. A scholar is included among the top collaborators of Deepa Rungta based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Deepa Rungta. Deepa Rungta is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Hudson, Andrew R., Robert I. Higuchi, Steven L. Roach, et al.. (2011). Nonsteroidal 2,3-dihydroquinoline glucocorticoid receptor agonists with reduced PEPCK activation. Bioorganic & Medicinal Chemistry Letters. 21(6). 1654–1657. 3 indexed citations
2.
Roach, Steven L., Robert I. Higuchi, Andrew R. Hudson, et al.. (2011). Tetrahydroquinolin-3-yl carbamate glucocorticoid receptor agonists with reduced PEPCK activation. Bioorganic & Medicinal Chemistry Letters. 21(6). 1658–1662. 1 indexed citations
3.
Marschke, Keith B., Deepa Rungta, Daniela A Slavin, et al.. (2011). Discovery of Non-Peptidyl Small-Molecule Human GCSF Receptor Agonists for the Potential Treatment of Neutropenia,. Blood. 118(21). 3391–3391. 1 indexed citations
4.
López, Francisco J., Robert Ardecky, Bruce F. Bebo, et al.. (2008). LGD-5552, an Antiinflammatory Glucocorticoid Receptor Ligand with Reduced Side Effects, in Vivo. Endocrinology. 149(5). 2080–2089. 42 indexed citations
5.
Hudson, Andrew R., Steven L. Roach, Robert I. Higuchi, et al.. (2007). Synthesis and Characterization of Nonsteroidal Glucocorticoid Receptor Modulators for Multiple Myeloma. Journal of Medicinal Chemistry. 50(19). 4699–4709. 28 indexed citations
6.
Michellys, Pierre‐Yves, Timothy A. Grese, Donald S. Karanewsky, et al.. (2004). Design, synthesis and structure–activity relationship of novel RXR-selective modulators. Bioorganic & Medicinal Chemistry Letters. 14(6). 1593–1598. 16 indexed citations
7.
Gernert, Douglas L., David A. Neel, Mark D. Leibowitz, et al.. (2004). Design and synthesis of benzofused heterocyclic RXR modulators. Bioorganic & Medicinal Chemistry Letters. 14(11). 2759–2763. 9 indexed citations
8.
Michellys, Pierre‐Yves, Marcus F. Boehm, Timothy A. Grese, et al.. (2003). Design and synthesis of novel RXR-selective modulators with improved pharmacological profile. Bioorganic & Medicinal Chemistry Letters. 13(22). 4071–4075. 21 indexed citations
9.
Gernert, Douglas L., Rose T. Ajamie, Mike Bell, et al.. (2003). Design and synthesis of fluorinated RXR modulators. Bioorganic & Medicinal Chemistry Letters. 13(19). 3191–3195. 16 indexed citations
10.
Xu, Yanping, Xiaodong Wang, R. C. Thompson, et al.. (2003). Design and Synthesis of a Potent and Selective Triazolone-Based Peroxisome Proliferator-Activated Receptor α Agonist. Journal of Medicinal Chemistry. 46(24). 5121–5124. 52 indexed citations
11.
Michellys, Pierre‐Yves, Robert Ardecky, Timothy A. Grese, et al.. (2003). Design, Synthesis, and Structure−Activity Relationship Studies of Novel 6,7-Locked-[7-(2-alkoxy-3,5-dialkylbenzene)-3-methylocta]-2,4,6-trienoic Acids. Journal of Medicinal Chemistry. 46(19). 4087–4103. 25 indexed citations
12.
Rosen, Jon, Keith B. Marschke, & Deepa Rungta. (2003). Nuclear hormone receptor assays for drug discovery.. PubMed. 6(2). 224–30. 6 indexed citations
13.
Cesario, Rosemary M., Kay Klausing, Diane L. Crombie, et al.. (2001). The Rexinoid LG100754 Is a Novel RXR:PPARγ Agonist and Decreases Glucose Levelsin Vivo. Molecular Endocrinology. 15(8). 1360–1369. 67 indexed citations
14.
Yarovoi, Serge, Xianping Lu, Nathalie Picard, et al.. (1998). Selective Activation of an Apoptotic Retinoid Precursor in Macrophage Cell Lines. Journal of Biological Chemistry. 273(33). 20852–20859. 3 indexed citations
15.
Lu, Xianping, Andrea Fanjul, Nathalie Picard, et al.. (1997). Novel retinoid-related molecules as apoptosis inducers and effectve inhibitors of human lung cancer cells in vivo. Nature Medicine. 3(6). 686–690. 71 indexed citations
16.
Rungta, Deepa, et al.. (1996). Regulation of Tyrosinase mRNA in Mouse Melanoma Cells by α-Melanocyte–Stimulating Hormone. Journal of Investigative Dermatology. 107(5). 689–693. 10 indexed citations
17.
Fuller, Bryan B., et al.. (1993). Hormonal Regulation of Melanogenesis in Mouse Melanoma and in Human Melanocytes. Annals of the New York Academy of Sciences. 680(1). 302–319. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026